[In vitro evaluation of antibacterial activity of extract of Salvia officinalis and Carum copticum against cariogenic microorganisms]

Based on the attraction of the world society to traditional treatment and the importance of drug extraction of natural material and plants, in this in vitro study the effect of hydroalcoholic extract of Salvia officinalis and Carum copticum which are very useful in the traditional treatment of mouth and teeth disease have been determined against cariogenic bacteria. In this experimental study, hydroalcoholic extracts have been prepared after sterilization of the extracts by special filter from Salvia officinalis and Carum copticum using the maceration method [serial dilution of the sample by the method]. Their antibacterial activity against Streptococcus mutans, Lactobacillus rhamnosus and Actinomyces viscosus have been evaluated by the broth macrodilution method. Results have been analyzed with Mann-Whitney test. MIC [Minimum Inhibitory Concentration] of Salvia officinalis and Carum copticum for Streptococcus mutans were 6.25 and 12.5 micro gram per milliliter, respectively, These figures were 1.56 and 6.25 micro gram per milliliter for Lactobacillus rhamnosus and 12.5 and 25 micro gram per milliliter for Actinomyces viscosus. Both extracts had inhibitory effects on growth in all three bacterial species. Salvia officinalis had a greater effect on inhibition of growth in all three bacterial species. Salvia officinalis also had a bactericidal effect in the range of concentration

Antimicrobial susceptibility testing for escherichia coli strains to fluoroquinolones, in urinary tract infections

Urinary Tract Infections [UTIs] are one of the most common infectious diseases diagnosed all over the world. Meanwhile most episode of UTIs are caused by Escherichia coli [up to 85%] and frequently fluoroquinolones are preferred as initial agents for empiric therapy of UTIs. Widespread use of fluoroquinolones has resulted in an increasing incidence of resistance these agents all over the world. The aim of this study was to assess, susceptibility of Escherichia coli strains from UTI patients against common fluoroquinolones. Antimicrobial susceptibility testing was determined by disk agar diffusion [DAD] and Minimal Inhibitory Concentration methods as described by the National Committee for Clinical Laboratory Standards [NCCLS]. One hundred sixty four clinical isolates of E. coli were collected by urine cultures from patients with UTI. The extent of resistant to nalidixic acid, ofloxacin, norfloxacin and ciprofloxacin, by disk diffusion method was 49.3%, 44.5%, 41.4% and 40.2%, respectively. Resistance to ciprofloxacin by MIC method was 4.9%. This study represents high level resistant of E. coli isolates from UTI patients. It is because of inappropriate and incorrect administration of antimicrobial agents in blind cases. This problem remarks significance of performing antimicrobial susceptibility testing before empiric antibiotic therapy. To overcome this problem use of unnecessary antibiotics therapy should be limited